Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma
Yanfang Liang, Bihua Lin, Ziyu Ye, Shasha Chen, Haibo Yu, Can Chen, Xin Zhang, Keyuan Zhou, Jincheng Zeng · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2020
Abstract
Endometrial carcinoma (EC) is the most common malignant tumors in female derived from the endometrial epithelium.Several previous studies have described estrogen receptors (ER), progesterone Receptor (PR) and phosphatase and tensin homolog (PTEN) are associated with clinicopathological factors and prognosis in EC patients.However, during EC patients follow-up, we found that some EC patients with down-regulation of PTEN, but up-regulation of ER or PR , and some EC patients with down-regulation of ER or PR, but up-regulation of PTEN also had a poor prognosis.Therefore, to reveal the prognosis of EC patients with different phenotypes based on PTEN, ER and PR expression, 120 cases formalin-fixed paraffin-embedded EC tissues and 543 cases uterine corpus endometrial carcinoma (UCEC) patients from the cancer genome atlas (TCGA) UCEC datasets were analyzed.Results showed that EC tissues can be classified to, and PTEN L ER H PR L phenotypes basing on IHC analysis.Additionally, EC patients with PTEN L ER L PR L showed high malignancy, while patients with PTEN H ER H PR H showed low malignancy.Therefore, combined detection of PTEN, ER, PR may help identify a small subset of EC with more aggressive behavior and may aid in risk stratification.
Open the resolved locator · 10.7150/jca.33720
Metadata licence: OpenAlex metadata (CC0)